Microcap biotech firm Neuralstem (CUR +7.8%) finishes the day with a solid gain after it saying...


Microcap biotech firm Neuralstem (CUR +7.8%) finishes the day with a solid gain after it saying it received a notice of allowance from the U.S. Patent and Trademark Office for an application pertaining its method for delivering a therapeutic agent to a spinal cord target.

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs